Literature DB >> 22762050

Different expression pattern of serum soluble intercellular adhesion molecules-1 and neutrophilic expression of CD18 in patients with diabetic retinopathy.

Hua Ai1, Hu-Ping Song.   

Abstract

AIM: To investigate the levels of serum soluble intercellular adhesion molecules-1(sICAM-1) and neutrophilic expression of CD18 in patients with various stages of diabetic retinopathy and to determine their different expression pattern in the development of diabetic retinopathy(DR).
METHODS: Levels of serum sICAM-1 and CD18 on the surface of neutrophile were measured in 41 DR patients, they were classified in three subgroups according to the stage of retinopathy as determined by fund's ophthalmoscopy; 10 control subjects were also studied. sICAM-1 were measured by enzyme-linked immunosorbent assay and CD18 by flow cytometry.
RESULTS: The neutrophilic CD18 expression and serum sICAM-1 level were all significantly elevated in all diabetic subgroups compared to control subjects (P<0.01). The differences of CD18 and sICAM-1 among the diabetic subgroups were significant in CD18 but not in sICAM-1. The progression of retinopathy was associated with an increase both in CD18 and in sICAM-1 levels by simple correlation analysis (β=0.74, P<0.001; β=0.38, P<0.01, respectively). But stepwise multiple regression analysis revealed that only CD18 was independent determinant of retinopathy (β=1.04, P<0.01).
CONCLUSION: Our results confirm the contribution of endothelial and neutrophilic activation in the development of DR as indicated by increased levels of CD18 and sICAM-1. However, a direct implication of CD18 and ICAM-1 in the progression of DR can be supported only in the CD18 but not ICAM-1. CD18 and ICAM-1 may play different role in the development of diabetic retinopathy.

Entities:  

Keywords:  CD18; diabetic retinopathy; neutrophilic; serum soluble intercellular adhesion molecules-1

Year:  2012        PMID: 22762050      PMCID: PMC3359038          DOI: 10.3980/j.issn.2222-3959.2012.02.17

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  30 in total

1.  Elevated plasma endothelin in patients with diabetes mellitus.

Authors:  K Takahashi; M A Ghatei; H C Lam; D J O'Halloran; S R Bloom
Journal:  Diabetologia       Date:  1990-05       Impact factor: 10.122

2.  Endothelial cell hypertrophy induced by vascular endothelial growth factor in the retina: new insights into the pathogenesis of capillary nonperfusion.

Authors:  P Hofman; B C van Blijswijk; P J Gaillard; G F Vrensen; R O Schlingemann
Journal:  Arch Ophthalmol       Date:  2001-06

Review 3.  Role of blood flow and impaired autoregulation in the pathogenesis of diabetic retinopathy.

Authors:  E M Kohner; V Patel; S M Rassam
Journal:  Diabetes       Date:  1995-06       Impact factor: 9.461

4.  Soluble adhesion molecules are not involved in the development of retinopathy in type 2 diabetic patients.

Authors:  M S Boulbou; G N Koukoulis; E A Petinaki; A Germenis; K I Gourgoulianis
Journal:  Acta Diabetol       Date:  2004-09       Impact factor: 4.280

5.  Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition.

Authors:  K Miyamoto; S Khosrof; S E Bursell; R Rohan; T Murata; A C Clermont; L P Aiello; Y Ogura; A P Adamis
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-14       Impact factor: 11.205

6.  Expression of CD18 on the neutrophils of patients with diabetic retinopathy.

Authors:  Huping Song; Lili Wang; Yannian Hui
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-07-18       Impact factor: 3.117

7.  The prevalence of diabetic retinopathy among adults in the United States.

Authors:  John H Kempen; Benita J O'Colmain; M Cristina Leske; Steven M Haffner; Ronald Klein; Scot E Moss; Hugh R Taylor; Richard F Hamman
Journal:  Arch Ophthalmol       Date:  2004-04

Review 8.  Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales.

Authors:  C P Wilkinson; Frederick L Ferris; Ronald E Klein; Paul P Lee; Carl David Agardh; Matthew Davis; Diana Dills; Anselm Kampik; R Pararajasegaram; Juan T Verdaguer
Journal:  Ophthalmology       Date:  2003-09       Impact factor: 12.079

9.  A central role for inflammation in the pathogenesis of diabetic retinopathy.

Authors:  Antonia M Joussen; Vassiliki Poulaki; Minh Ly Le; Kan Koizumi; Christina Esser; Hanna Janicki; Ulrich Schraermeyer; Norbert Kociok; Sascha Fauser; Bernd Kirchhof; Timothy S Kern; Anthony P Adamis
Journal:  FASEB J       Date:  2004-07-01       Impact factor: 5.191

10.  Comparison of serum concentrations of soluble adhesion molecules in diabetic microangiopathy and macroangiopathy.

Authors:  K Matsumoto; Y Sera; Y Ueki; G Inukai; E Niiro; S Miyake
Journal:  Diabet Med       Date:  2002-10       Impact factor: 4.359

View more
  4 in total

1.  The predictive role of markers of Inflammation and endothelial dysfunction on the course of diabetic retinopathy in type 1 diabetes.

Authors:  Hussein A Rajab; Nathaniel L Baker; Kelly J Hunt; Richard Klein; Patricia A Cleary; John Lachin; Gabriel Virella; Maria F Lopes-Virella
Journal:  J Diabetes Complications       Date:  2014-08-20       Impact factor: 2.852

Review 2.  A meta-analysis of prognostic biomarkers in neonatal retinal hemorrhage.

Authors:  Yan Xu; Ying Wang; Shouqing Li
Journal:  Int Ophthalmol       Date:  2021-10-08       Impact factor: 2.031

Review 3.  The role of inflammation in the pathogenesis of macular edema secondary to retinal vascular diseases.

Authors:  Francisco J Ascaso; Valentín Huerva; Andrzej Grzybowski
Journal:  Mediators Inflamm       Date:  2014-07-22       Impact factor: 4.711

4.  Fundus fluorescence Angiography in diagnosing diabetic retinopathy.

Authors:  Shuhui Wang; Yuqin Zuo; Ning Wang; Bin Tong
Journal:  Pak J Med Sci       Date:  2017 Nov-Dec       Impact factor: 1.088

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.